Why would pharm stock nexafed when ACUR wants to be a software Co. with 2.0 that is 99% or 100%? meth resistant. 1.0 is only 62%. I would wait to stock nexafed until 2.0 is ready. Good Luck. Could be 1 reason for lack of sales, anyone agree
I think you are writing to the wrong crowd, most of the people here are already in. Given that the product is already on 2,600 stores, I don't think that lack of sales is a problem, I am sure it is going to pick up speed in the following months.
I have been here 9 years. If my sale(1 Brad) staff only got 4% in 9 months they would be fired. I have 4k shrs @ 1.52 plus my core. I want ACUR to do well, but not another 9 years. I was just saying. GOOD LUCK